Sonora Investment Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $10K | Hold |
100
| – | – | ﹤0.01% | 781 |
|
|
2021
Q2 | $10K | Hold |
100
| – | – | ﹤0.01% | 714 |
|
|
2021
Q1 | $10K | Hold |
100
| – | – | ﹤0.01% | 1283 |
|
|
2020
Q4 | $10K | Hold |
100
| – | – | ﹤0.01% | 1227 |
|
|
2020
Q3 | $10K | Sell |
100
-8
| -7% | -$800 | ﹤0.01% | 1211 |
|
|
2020
Q2 | $13K | Buy |
108
+8
| +8% | +$963 | ﹤0.01% | 948 |
|
|
2020
Q1 | $9K | Hold |
100
| – | – | ﹤0.01% | 1124 |
|
|
2019
Q4 | $11K | Hold |
100
| – | – | ﹤0.01% | 1131 |
|
|
2019
Q3 | $9K | Hold |
100
| – | – | ﹤0.01% | 1268 |
|
|
2019
Q2 | $8K | Hold |
100
| – | – | ﹤0.01% | 1263 |
|
|
2019
Q1 | $9K | Hold |
100
| – | – | ﹤0.01% | 1097 |
|
|
2018
Q4 | $7K | Hold |
100
| – | – | ﹤0.01% | 958 |
|
|
2018
Q3 | $12K | Hold |
100
| – | – | ﹤0.01% | 798 |
|
|
2018
Q2 | $10K | Hold |
100
| – | – | ﹤0.01% | 808 |
|
|
2018
Q1 | $8.29K | Hold |
100
| – | – | ﹤0.01% | 844 |
|
|
2017
Q4 | $7.76K | Hold |
100
| – | – | ﹤0.01% | 867 |
|
|
2017
Q3 | $6.13K | Hold |
100
| – | – | ﹤0.01% | 820 |
|
|
2017
Q2 | $4.6K | Sell |
100
-100
| -50% | -$4.6K | ﹤0.01% | 849 |
|
|
2017
Q1 | $8.66K | Buy |
+200
| New | +$8.66K | ﹤0.01% | 718 |
|